Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarsha L Harris

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|May 8, 2015
Drak2 Does Not Regulate TGF-β Signaling in T CellsTarsha L Harris, Maureen A McGargill
Immunology and Cell Biology|July 5, 2018
Potential killers exposed: tracking endogenous influenza-specific CD8<sup>+</sup> T cellsRachael Keating, Melissa Y Morris, Wen Yue, et al.
Journal of Cell Science|October 18, 2024
DRAK2 regulates myosin light chain phosphorylation in T cellsBenjamin A Wilander, Tarsha L Harris, Alexandra H Mandarano, et al.
Vision Research|March 23, 2007
Estimation of macular pigment optical density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjectsKevin T Gallaher, Marco Mura, Wm Andrew Todd, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Investigative Ophthalmology & Visual Science|March 29, 2007
Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sampleAlessandro Iannaccone, Marco Mura, Kevin T Gallaher, et al.
Cell Reports|February 11, 2023
DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell developmentAlexandra H Mandarano, Tarsha L Harris, Blaine M Creasy, et al.
Nature Immunology|October 22, 2013
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virusRachael Keating, Tomer Hertz, Marie Wehenkel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|May 8, 2015
Drak2 Does Not Regulate TGF-β Signaling in T CellsTarsha L Harris, Maureen A McGargill
Immunology and Cell Biology|July 5, 2018
Potential killers exposed: tracking endogenous influenza-specific CD8<sup>+</sup> T cellsRachael Keating, Melissa Y Morris, Wen Yue, et al.
Journal of Cell Science|October 18, 2024
DRAK2 regulates myosin light chain phosphorylation in T cellsBenjamin A Wilander, Tarsha L Harris, Alexandra H Mandarano, et al.
Vision Research|March 23, 2007
Estimation of macular pigment optical density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjectsKevin T Gallaher, Marco Mura, Wm Andrew Todd, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Investigative Ophthalmology & Visual Science|March 29, 2007
Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sampleAlessandro Iannaccone, Marco Mura, Kevin T Gallaher, et al.
Cell Reports|February 11, 2023
DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell developmentAlexandra H Mandarano, Tarsha L Harris, Blaine M Creasy, et al.
Nature Immunology|October 22, 2013
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virusRachael Keating, Tomer Hertz, Marie Wehenkel, et al.
Pageof 1